Literature DB >> 29415170

Developing androgen receptor targeting for salivary gland cancers.

A L Ho1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29415170      PMCID: PMC5913640          DOI: 10.1093/annonc/mdy042

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  20 in total

1.  Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.

Authors:  Lindsay Williams; Lester D R Thompson; Raja R Seethala; Ilan Weinreb; Adel M Assaad; Madalina Tuluc; Nasir Ud Din; Bibianna Purgina; Chi Lai; Christopher C Griffith; Simion I Chiosea
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

2.  Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.

Authors:  Martin G Dalin; Alexis Desrichard; Nora Katabi; Vladimir Makarov; Logan A Walsh; Ken-Wing Lee; Qingguo Wang; Joshua Armenia; Lyndsay West; Snjezana Dogan; Lu Wang; Deepa Ramaswami; Alan L Ho; Ian Ganly; David B Solit; Michael F Berger; Nikolaus D Schultz; Jorge S Reis-Filho; Timothy A Chan; Luc G T Morris
Journal:  Clin Cancer Res       Date:  2016-04-21       Impact factor: 12.531

3.  Blockade of Androgen-induced Malignant Phenotypes by Flutamide Administration in Human Salivary Duct Carcinoma Cells.

Authors:  Y U Kamata; Tomoki Sumida; Ryuichi Murase; Hiroyuki Nakano; Tomohiro Yamada; Yoshihide Mori
Journal:  Anticancer Res       Date:  2016-11       Impact factor: 2.480

4.  Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.

Authors:  David J Mulholland; Linh M Tran; Yunfeng Li; Houjian Cai; Ashkan Morim; Shunyou Wang; Seema Plaisier; Isla P Garraway; Jiaoti Huang; Thomas G Graeber; Hong Wu
Journal:  Cancer Cell       Date:  2011-05-27       Impact factor: 31.743

5.  Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.

Authors:  Laura D Locati; Federica Perrone; Barbara Cortelazzi; Salvatore Lo Vullo; Paolo Bossi; Gianpaolo Dagrada; Pasquale Quattrone; Cristiana Bergamini; Paolo Potepan; Enrico Civelli; Carlo Fallai; Silvana Pilotti; Lisa Licitra
Journal:  Head Neck       Date:  2015-06-25       Impact factor: 3.147

6.  Abiraterone in metastatic salivary duct carcinoma.

Authors:  Damien Urban; Danny Rischin; Christopher Angel; Ieta D'Costa; Benjamin Solomon
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

7.  Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.

Authors:  Tatsuo Masubuchi; Yuichiro Tada; Shin-ichiro Maruya; Yoshiyuki Osamura; Shin-etsu Kamata; Kouki Miura; Chihiro Fushimi; Hideaki Takahashi; Daisuke Kawakita; Seiji Kishimoto; Toshitaka Nagao
Journal:  Int J Clin Oncol       Date:  2014-02-20       Impact factor: 3.402

8.  Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.

Authors:  Michelle D Williams; Dianna Roberts; George R Blumenschein; Stephane Temam; Merrill S Kies; David I Rosenthal; Randal S Weber; Adel K El-Naggar
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

9.  Integrative clinical genomics of advanced prostate cancer.

Authors:  Dan Robinson; Eliezer M Van Allen; Yi-Mi Wu; Nikolaus Schultz; Robert J Lonigro; Juan-Miguel Mosquera; Bruce Montgomery; Mary-Ellen Taplin; Colin C Pritchard; Gerhardt Attard; Himisha Beltran; Wassim Abida; Robert K Bradley; Jake Vinson; Xuhong Cao; Pankaj Vats; Lakshmi P Kunju; Maha Hussain; Felix Y Feng; Scott A Tomlins; Kathleen A Cooney; David C Smith; Christine Brennan; Javed Siddiqui; Rohit Mehra; Yu Chen; Dana E Rathkopf; Michael J Morris; Stephen B Solomon; Jeremy C Durack; Victor E Reuter; Anuradha Gopalan; Jianjiong Gao; Massimo Loda; Rosina T Lis; Michaela Bowden; Stephen P Balk; Glenn Gaviola; Carrie Sougnez; Manaswi Gupta; Evan Y Yu; Elahe A Mostaghel; Heather H Cheng; Hyojeong Mulcahy; Lawrence D True; Stephen R Plymate; Heidi Dvinge; Roberta Ferraldeschi; Penny Flohr; Susana Miranda; Zafeiris Zafeiriou; Nina Tunariu; Joaquin Mateo; Raquel Perez-Lopez; Francesca Demichelis; Brian D Robinson; Marc Schiffman; David M Nanus; Scott T Tagawa; Alexandros Sigaras; Kenneth W Eng; Olivier Elemento; Andrea Sboner; Elisabeth I Heath; Howard I Scher; Kenneth J Pienta; Philip Kantoff; Johann S de Bono; Mark A Rubin; Peter S Nelson; Levi A Garraway; Charles L Sawyers; Arul M Chinnaiyan
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

10.  Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.

Authors:  J S Ross; L M Gay; K Wang; J A Vergilio; J Suh; S Ramkissoon; H Somerset; J M Johnson; J Russell; S Ali; A B Schrock; D Fabrizio; G Frampton; V Miller; P J Stephens; J A Elvin; D W Bowles
Journal:  Ann Oncol       Date:  2017-10-01       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.